Arbitr
Use cases▾
PlatformPricing
Resources▾
Explore
About▾
The company
Book a demo
Home > Regulations > Supplement Structure/Function Claims (21 CFR 101.93)

DSHEA 1994; 21 U.S.C. 343(r)(6); 21 CFR 101.93

US dietary supplement structure/function claims

For supplement brands and their marketing teams working out which structure/function claims they can make and what the label carries. This page covers what you need to know and ways to avoid running into issues.

What we've seen reported

Structure/function claims for US dietary supplement labels, set out in DSHEA, 21 U.S.C. 343(r)(6) and 21 CFR 101.93, describe a nutrient's role in the body's structure or function, carried with an FDA disclaimer and a 30-day notice.1,2

Last updated October 2026 · General information only, not legal advice. Sources.

Who it covers
Manufacturers, packers and distributors of dietary supplements that make these statements, according to its text2
Applies from
October 25, 19941Structure/function definitions added to 21 CFR 101.93 on January 6, 20003
Region
United States1

What the rules cover

Common phrases to watch out for

These are the kinds of wording the structure/function rules for US dietary supplements describe, according to 21 CFR 101.93 and FDA's compliance guide, and how they tend to show up on labels and in marketing.2,3

Phrase or termIn practice
"Supports healthy joints", "promotes restful sleep"Wording about a nutrient's role in structure or function, described as permitted with the disclaimer and notice.
"Reduces arthritis pain", "fights infection"Wording about a disease or its symptoms, which the rule treats as a disease claim.
"Maintains healthy cholesterol" vs "lowers cholesterol"Keeping a normal function is described as structure/function; lowering a disease marker is not.
Product names that suggest a diseaseA product name can, on its own, carry an implied disease claim.
Study titles, images and symbolsA cited title or picture that points to a disease can make the claim a disease claim.
"Treats", "cures", "prevents"The disclaimer states the product is not intended to diagnose, treat, cure or prevent any disease.
The FDA disclaimer and asteriskNext to the claim or linked by a symbol, in bold type of at least 1/16 inch.

Where it goes wrong

Approved once. Then it drifts.

One approved claim ends up in many channels, markets and languages. Along the way it gets shortened, translated and reworded, and some versions end up using the very phrases you are trying to avoid.

Approved onceIllustrative example

"Supports healthy joint flexibility.*" with the FDA disclaimer

  • Bottle · USSupports healthy joint flexibility.* Disclaimer on the back
  • Social · USDriftedSay goodbye to arthritis painUses "arthritis"
  • Website · USSupports healthy joint flexibility, with the disclaimer
  • Marketplace listing · USDriftedSupports healthy joint flexibility; asterisk and disclaimer droppedFDA disclaimer missing
  • Retailer sell sheet · USClaim and disclaimer as approved
  • Website · US SpanishFavorece la flexibilidad articular saludable.* "Supports healthy joint flexibility.*"

How Arbitr helps

So how do you manage supplement claims at scale, across every market and channel you operate in?

Manually review everything? Or do what modern teams do and use AI to check that what you publish matches what you approved.

Check everything manually?

  • Too much to check. More versions go out every week than anyone can read in every language.
  • Drift goes unseen. Nothing tells you when a version moves away from the approved claim.
  • Changes mean starting over. No easy way to re-check what's live when your approved rules, claims or terms change.

Let Arbitr do it for you

  • Scan what's live. Check everything you've already published against your approved rules, and find every post or listing where a claim has picked up disease wording or lost its disclaimer.
  • See what needs attention. Get a clear report of anything that might have moved away from what was approved.
  • Check what comes next. Check new content against what you approved before it goes live, in every channel, market and language.

Approve once. Apply everywhere.

FAQ

Questions about US dietary supplement structure/function claims

For your teams
Where do supplement claims drift into disease language?

Usually in the copy written fastest. FDA's rule treats wording about a disease or its symptoms as a disease claim,2 and we usually find that kind of wording in:

  • social posts and short video captions
  • affiliate and influencer content
  • customer reviews quoted in ads
  • marketplace titles and bullet points
  • translated product pages
How should affiliates and influencers get approved supplement claims?

In writing, before they post. Give them the approved structure/function wording, the disclaimer, and the disease words to avoid, then ask to see each post before it goes live. Affiliate copy is where "supports" turns into "relieves". Our marketing compliance page shows how teams track this.

What goes into the file behind each structure/function claim?

Keep one record per claim: the approved wording, the substantiation behind it, the date of the FDA notice, the products it covers, who approved it, and every label, page and ad that carries it. The statute expects substantiation that a statement is truthful and not misleading,1 so that record is worth having before anyone asks.

How it applies to a specific claim is a question for your legal adviser. Where that claim appears across your markets and languages is a question Arbitr answers.

Which teams write supplement claims day to day?

Regulatory teams approve them, but brand, e-commerce, social, sales and customer service teams write new versions every week, and so do agencies. A short briefing for each, using your own claims, helps. Rules in other markets, such as UK medicines advertising, are on our health claims hub.

About the rules
What is a structure/function claim under DSHEA?

A statement describing how a nutrient or dietary ingredient affects the structure or function of the body, or the mechanism by which it maintains it, according to 21 CFR 101.93(f). The statement cannot also be a disease claim under the same section.2

Does the FDA approve structure/function claims before they are used?

It doesn't review them in advance. According to 21 CFR 101.93, the firm notifies FDA within 30 days after first marketing, and the label disclaimer says the statement has not been evaluated by the Food and Drug Administration.2

What does the FDA supplement disclaimer say?

For one statement, 21 CFR 101.93(c) gives the text: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." A plural version covers several statements.2

About Arbitr
Can Arbitr check content in other languages?

Yes. Each language version is checked against the approved original and your rules for that market. Where you want a person to look, it goes to your own reviewers or to one of Arbitr's experts.